MedTrace Logo

A Pilot Study of a Neural Mobilization Intervention Applied to Older Adults With Chronic Musculoskeletal Pain

NCT06138314 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-07-16

No results posted yet for this study

Summary

The goal of this pilot study is to evaluate the feasibility of integrating neural mobilization techniques into a multimodal physical exercise program for older adults with chronic musculoskeletal pain. The main questions it aims to answer are:

* What is the average time to assess secondary outcomes for each participant?
* What proportion of participants adhered and/or withdrew from the study at the end of the intervention protocol?
* Are there adverse events/effects associated with the intervention protocol?
* What is the level of approval/satisfaction of the participants in relation to the assessment and intervention protocols?
* What is the impact of the intervention protocol on participants´ pain, function, physical performance, somatosensory function, and nerve excursion (secondary outcomes)?

Participants will be assessed at 3 different moments: initial assessment (T0), at the end of the intervention protocol (8 weeks) (T1) and 3 months after the end of the intervention protocol (T2). The intervention protocol will consist of a multimodal exercise program (with or without integration of neural mobilization techniques) to be carried out over a period of 8 weeks at a frequency of twice a week.

Conditions

  • Chronic Musculoskeletal Pain
  • Chronic Pain
  • Chronic Musculoskeletal Disease
  • Older Adults

Interventions

OTHER

Physical Exercise Program

The physical exercise program will consist of exercises from three different exercise modalities: aerobic training, balance exercises, and isometric exercises.

OTHER

Neural Mobilization

Neural mobilization techniques for the upper and lower quadrants will be actively performed by participants.

Sponsors & Collaborators

  • Aveiro University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-12
Primary Completion
2024-04-12
Completion
2024-07-13

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06138314 on ClinicalTrials.gov